MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Operating income 2021–2025
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) annual operating income history from SEC filings — each fiscal year as reported.
-$244.8MFY2025 · since FY2021: -$4.6M → -$244.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$244.8M | -71.1% |
| FY2024 | -$143.1M | -164.4% |
| FY2023 | -$54.1M | +16.8% |
| FY2022 | -$65.1M | -1323.6% |
| FY2021 | -$4.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice